RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is therefore likely that, like for the additional alterations such as trisomy 8 and isochromosome 17q, the observed EVI1 overexpression contributes to the aggressive phenotype of the blastic CML phase.